Author
Listed:
- Rileen Sinha
(Memorial Sloan-Kettering Cancer Center
Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai)
- Andrew G. Winer
(Urology Service, Memorial Sloan-Kettering Cancer Center)
- Michael Chevinsky
(Urology Service, Memorial Sloan-Kettering Cancer Center)
- Christopher Jakubowski
(Urology Service, Memorial Sloan-Kettering Cancer Center)
- Ying-Bei Chen
(Memorial Sloan-Kettering Cancer Center)
- Yiyu Dong
(Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center)
- Satish K. Tickoo
(Memorial Sloan-Kettering Cancer Center)
- Victor E. Reuter
(Memorial Sloan-Kettering Cancer Center)
- Paul Russo
(Urology Service, Memorial Sloan-Kettering Cancer Center)
- Jonathan A. Coleman
(Urology Service, Memorial Sloan-Kettering Cancer Center)
- Chris Sander
(cBio Center, Dana-Farber Cancer Institute and Compbio Collaboratory, Harvard Medical School)
- James J. Hsieh
(Molecular Oncology, Siteman Cancer Center, Washington University)
- A. Ari Hakimi
(Memorial Sloan-Kettering Cancer Center
Urology Service, Memorial Sloan-Kettering Cancer Center)
Abstract
The utility of cancer cell lines is affected by the similarity to endogenous tumour cells. Here we compare genomic data from 65 kidney-derived cell lines from the Cancer Cell Line Encyclopedia and the COSMIC Cell Lines Project to three renal cancer subtypes from The Cancer Genome Atlas: clear cell renal cell carcinoma (ccRCC, also known as kidney renal clear cell carcinoma), papillary (pRCC, also known as kidney papillary) and chromophobe (chRCC, also known as kidney chromophobe) renal cell carcinoma. Clustering copy number alterations shows that most cell lines resemble ccRCC, a few (including some often used as models of ccRCC) resemble pRCC, and none resemble chRCC. Human ccRCC tumours clustering with cell lines display clinical and genomic features of more aggressive disease, suggesting that cell lines best represent aggressive tumours. We stratify mutations and copy number alterations for important kidney cancer genes by the consistency between databases, and classify cell lines into established gene expression-based indolent and aggressive subtypes. Our results could aid investigators in analysing appropriate renal cancer cell lines.
Suggested Citation
Rileen Sinha & Andrew G. Winer & Michael Chevinsky & Christopher Jakubowski & Ying-Bei Chen & Yiyu Dong & Satish K. Tickoo & Victor E. Reuter & Paul Russo & Jonathan A. Coleman & Chris Sander & James , 2017.
"Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection,"
Nature Communications, Nature, vol. 8(1), pages 1-10, August.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15165
DOI: 10.1038/ncomms15165
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15165. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.